
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Genet.
Sec. Cancer Genetics and Oncogenomics
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1541541
The final, formatted version of the article will be published soon.
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
AbstractObjective: RNA methylation modifications play biological roles in tumorigenicity and immune response, mainly mediated by the "writer" enzyme. Lung adenocarcinoma (LUAD) development is closely related to RNA methylation. Here, the prognostic values of the "writer" enzymes and the tumor immunosurveillance in LUAD aim to provide new theoretical references for the research of LUAD.Methods: Genes associated with RNA methylation writer protein in LUAD were identified using The Cancer Genome Atlas Program (TCGA) data and weighted gene co-expression network analysis (WGCNA). Independent prognostic factors were screened by Cox regression and least absolute shrinkage and selection operator (LASSO) regression analyses. A prognostic risk model and a nomogram were established using these genes. Moreover, Gene Set Enrichment Analysis (GSEA) and CIBERSORTx were used to analyze the immune cell infiltration and enrichment pathways in the low- and high-risk groups, respectively. In addition, genes' potential functions and regulatory mechanisms were explored through gene-gene interaction (GGI) networks and competing endogenous RNA (ceRNA) networks.Results: We selected 202 genes associated with RNA methylation writer proteins, from which we identified the three genes (CLEC3B, GRIA1, and ANOS1). A prognostic risk model was constructed based on genes associated with RNA methylation writer proteins and stage, demonstrating reliable predictive performance. GGI analysis revealed GRIA1 as a crucial gene. Enrichment analysis revealed that the high-risk group had up-regulated pathways connected to cell division. Additionally, immune infiltration analysis revealed that the significantly higher levels of NK cells, activated mast cells, activated CD4 memory cells, and M0 and M1 macrophages displayed in the high-risk group, while the significantly lower levels of monocytes, dendritic cells, M2 macrophages, and inactive CD4 memory cells were in the low-risk group. Moreover, Spearman correlation analysis demonstrated that the three prognostic genes and risk scores correlated highly with various immune cells. Conclusion: This study identified three prognostic genes related to RNA methylation writer proteins in LUAD. A reliable prognostic model was constructed. The identified prognostic genes also play significant roles in immune cell infiltration in LUAD. This study provides new theoretical references for subsequent in-depth research on LUAD.
Keywords: Lung Adenocarcinoma, RNA methylation writer proteins, biomarker, prognostic risk mode, limmune cell infiltration
Received: 20 Dec 2024; Accepted: 09 Apr 2025.
Copyright: © 2025 Yin, Luo and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lei Luo, Guizhou Provincial People's Hospital, Guiyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Supplementary Material
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.